Retraction notice to "Mesoporous polydopamine (MPDA)-based drug delivery system for oral chemo-photothermal combinational therapy of orthotopic colon cancer" [Int. J. Biol. Macromol. 281 (2024) 136618].
0/5 보강
APA
Gu D, Liu Y, et al. (2025). Retraction notice to "Mesoporous polydopamine (MPDA)-based drug delivery system for oral chemo-photothermal combinational therapy of orthotopic colon cancer" [Int. J. Biol. Macromol. 281 (2024) 136618].. International journal of biological macromolecules, 327(Pt 1), 146661. https://doi.org/10.1016/j.ijbiomac.2025.146661
MLA
Gu D, et al.. "Retraction notice to "Mesoporous polydopamine (MPDA)-based drug delivery system for oral chemo-photothermal combinational therapy of orthotopic colon cancer" [Int. J. Biol. Macromol. 281 (2024) 136618].." International journal of biological macromolecules, vol. 327, no. Pt 1, 2025, pp. 146661.
PMID
40912959 ↗
같은 제1저자의 인용 많은 논문 (3)
- Research progress on the mechanisms of action, pharmacological activities and clinical application of P-glycoprotein inhibitors.
- Comment on "Association between textbook outcome and long-term survival among patients undergoing curative-intent resection of gastric cancer".
- Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024.